Avista Pharma Solutions, Inc. has completed facility upgrades that effectively double the company’s API manufacturing capacity at its Longmont, Colorado site. During the expansion, the site’s three existing GMP drug substance manufacturing suites were upgraded, and a fourth GMP suite was added. The facility’s non-GMP capacity was also doubled with the addition of two largescale development suites. Among…

Avista Pharma Solutions, Inc. has announced that the expansion and upgrades to the Analytical Laboratories at its Durham, North Carolina facility are now complete. These enhancements will enable the company to significantly increase its capacity with a comprehensive range of capabilities for its pharmaceutical and medical device clients. Comprised of two laboratories, the Analytical Research and Development…